In the rapidly evolving landscape of healthcare, genetic testing is emerging as a pivotal force, promising to transform patient care through precision medicine. The insights derived from our genetic codes hold the potential to not only prevent diseases but also optimize treatments and promote healthier living. Yet, as highlighted in a recent MedCity News article, the journey towards realizing this potential is fraught with challenges, particularly around patient privacy and data sharing.
The Role of Information Technology
A critical component in addressing these challenges is information technology security. Organizations are turning to certifications like HITRUST to establish standards for safeguarding sensitive information. By aligning with these standards, they can protect data while facilitating the sharing necessary to enhance medical knowledge and patient care.
Collaborative Efforts and Data Sharing
Collaboration is at the heart of advancing genetic testing. Companies are contributing de-identified variant data to public health databases such as ClinVAR and the SEER Cancer Registries. These efforts, supported by cancer research registries, deepen insights and expedite advancements in patient care.
The analysis of expansive data sets is crucial for understanding diseases, allowing researchers to access, assess, and test hypotheses. This collaborative approach is paving the way for tailored treatment plans and new biological discoveries, enhancing early disease detection and intervention.
Integration with Electronic Health Records
Integrating genetic testing with Electronic Health Records (EHR) is another key strategy for improving patient outcomes. Collaborations with EHR vendors like Epic, Flatiron, and Athena streamline processes, making it easier for providers to order genetic products, optimize screening protocols, and identify potential pharmacogenetic interactions. Such collaborations break down silos, enhancing data exchange for more effective research and patient care.
Challenges and Future Trends
Despite the promising progress, the integration of genetic testing into mainstream medicine presents challenges, including managing the vast volume of genomic data. Companies are focusing on presenting complex clinical interpretations, integrating common data ontologies, overcoming data fragmentation, and ensuring data privacy to address these hurdles.
Looking ahead, the industry anticipates significant advancements, with trends like developing tests for early cancer recurrence detection and embracing a multi-omics approach that integrates RNA, proteins, and AI insights. The integration of generative AI for documentation and genetic counseling is another notable development on the horizon.
A New Era in Healthcare
Genetic testing represents more than just a scientific advancement; it signifies a fundamental shift in how we approach health and wellness. As public understanding grows and technology advances, we find ourselves at the dawn of a new era in healthcare, where our genetic code becomes a roadmap to better health and longevity.
About the Author
Kevin Haas, Ph.D., serves as the Chief Technology Officer at Myriad Genetics, where he leads the development of the precision medicine platform. With expertise in molecular simulation and machine learning, Haas is advancing genomics and digital patient/provider experiences. He has co-authored 16 peer-reviewed publications and nine patent applications, bringing a wealth of experience to his role.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Financial analysis remains one of the strongest career paths for professionals seeking high earnings, steady growth, and long-term stability. With median salaries above $100K, expanding demand across industries, and clear promotion tracks leading to senior leadership roles, the field offers both opportunity and resilience—even as AI reshapes the workplace. This article breaks down what analysts do, salary expectations, job outlook, industry demand, and whether this career is the right fit for you.
After losing their home in the Los Angeles wildfires, Jessica and Matt Conkle expected their insurance policy to help them rebuild. Instead, they found themselves trapped in delays, lowball offers, and endless adjuster changes — a struggle now shared by thousands across California. Their experience highlights a nationwide problem: insurers pulling back from climate‑risk areas, soaring premiums, shrinking coverage, and regulators under fire. For professionals in real estate, mortgage, and insurance, this growing instability is reshaping transactions, lending, risk assessment, and the future of homeownership in America.
Kansas City’s housing market is finally gaining momentum heading into 2026 as falling interest rates, new construction, and a renewed focus on affordable homes open the door for first‑time buyers. Economists say improved supply and softer mortgage rates could shift the market after a challenging 2025, giving real estate professionals and buyers a promising window of opportunity.
Nevada has become the first state to allow insurers to sell homeowners policies without wildfire protection—a move aimed at lowering premiums but raising concerns about consumer risk and mortgage barriers. The law introduces new wildfire‑only policies and a regulatory sandbox for insurance innovation, potentially setting a precedent for other Western states.
Investment groups across the U.S. are rapidly expanding into tax‑deferred real estate programs as demand for Delaware Statutory Trusts (DSTs) accelerates. Major players like Blackstone, Brookfield, Denholtz, and PREP are launching new offerings fueled by stronger market certainty, a historic generational wealth transfer, and renewed confidence in 1031 exchange benefits. As DSTs move into the mainstream, real estate professionals are finding new opportunities to guide clients through advanced tax‑advantaged investment strategies.
Canada’s proptech sector is evolving fast as AI adoption accelerates and investor caution forces startups to mature. Funding has tightened, growth rounds have slowed, and companies are shifting from rapid expansion to profitability and real product‑market fit. AI‑driven platforms like Mave are gaining traction, consolidation is rising, and government housing initiatives may boost construction‑focused tech. For real estate professionals, these trends signal a new industry standard where AI tools and ongoing education are essential to staying competitive.
